Long QT syndrome (LQTS), caused by an ion channel-related gene mutation, is a malignant heart disease with a clinical course of a high incidence of ventricular fibrillation and sudden cardiac death in the young.
The British Heart Foundation is funding a trial for an experimental drug that could prevent the life-threatening blood clots that are seen in the lungs of the patients with COVID-19 or those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Physician-scientists specializing in heart failure wanted to know: if their heart transplant patients contract COVID-19, would they have a different experience than the general public or others who are also immunosuppressed?
A group of over 120 researchers from various institutions across Europe has performed the first genome-wide association study to reveal host genetic factors that may contribute to respiratory failure in cases of coronavirus disease 209 (COVID-19).
Despite concerns expressed by some experts, common high blood pressure drugs did not increase the risk of contracting COVID-19 – or of developing severe disease – in a study of 12,594 patients.
As New York, California and other states begin to see their numbers of new COVID-19 cases level off or even slip, it might appear as if we’re nearing the end of the pandemic.
James Diaz, MD, MHA, MPH & TM, Dr PH, Professor and Head of Environmental Health Sciences at LSU Health New Orleans School of Public Health, has proposed a possible explanation for the severe lung complications being seen in some people diagnosed with COVID-19.
Cepheid has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its rapid molecular diagnostic test, Xpert Xpress SARS-CoV-2.
Cholesterol is transported around the body in the bloodstream on proteins called lipoproteins. There are two types of lipoprotein: low-density lipoprotein (LDL), which is sometimes called “bad” cholesterol and high-density lipoprotein (HDL), also referred to as “good cholesterol.”
New study results found that guideline-directed medical treatment is as effective as invasive procedures, such as coronary stenting, at preventing heart attack, stroke, and death in patients with stable coronary artery disease (CAD).
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!